Nutex Health Class Actions Reach Lead-Plaintiff Deadline as Law Firms Rally Investors
Investor notices cite allegations of inflated arbitration recoveries alongside faulty financial controls.
Overview
- Today, October 21, 2025, marks the final day for Nutex investors to move the court to serve as lead plaintiff in the federal securities litigation.
- Complaints filed in the Southern District of Texas cover purchases from August 8, 2024 through August 14, 2025.
- Filings claim third-party biller HaloMD exploited the IDR/arbitration process by submitting ineligible claims that generated outsized reimbursements for Nutex.
- Plaintiffs also highlight Nutex’s August 14 Form 10-Q delay and an August 21 disclosure that the Audit Committee determined prior statements require restatement following classification errors.
- Nutex disputes the short-seller allegations tied to Blue Orca’s July 22 report, which preceded a share drop of over 10%, and the cases now proceed to lead-plaintiff selection and potential class certification.